DCM
DSCI

DAFNA Capital Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

DAFNA Capital Management’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-353,718
Closed -$1.84M – 83
2016
Q4 		$1.84M Hold
353,718
– – 1.62% 24
2016
Q3 		$1.65M Hold
353,718
– – 1.15% 29
2016
Q2 		$1.39M Hold
353,718
– – 1.1% 30
2016
Q1 		$1.1M Hold
353,718
– – 0.95% 32
2015
Q4 		$1.62M Sell
353,718
-3,200
-0.9% -$15.2K 1.44% 22
2015
Q3 		$1.68M Sell
356,918
-17,000
-5% -$110K 1.67% 17
2015
Q2 		$2.68M Hold
373,918
– – 2.26% 13
2015
Q1 		$3.17M Sell
373,918
-10,876
-3% -$92.6K 2.43% 9
2014
Q4 		$3.58M Hold
384,794
– – 2.83% 10
2014
Q3 		$3.21M Hold
384,794
– – 3.23% 9
2014
Q2 		$4.45M Hold
384,794
– – 4.22% 7
2014
Q1 		$4.88M Buy
384,794
+327,785
+575% +$4.24M 4.19% 10
2013
Q4 		$617K Hold
57,009
– – 0.64% 34
2013
Q3 		$706K Hold
57,009
– – 0.77% 33
2013
Q2 		$761K Buy
+57,009
New +$733K 1.11% 26

Other funds holding DSCI

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

DAFNA Capital Management's DSCI Position: Q1 2017 in Review

DAFNA Capital Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 353,718 shares — an estimated $1.84M sold.

DAFNA Capital Management first reported a position in DSCI in Q2 2013 and held it in 15 quarters. The position peaked at $4.88M in Q1 2014. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

  • DAFNA Capital Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
  • DAFNA Capital Management sold 353,718 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $1.84M.
  • DAFNA Capital Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 15 quarters.
  • DAFNA Capital Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $4.88M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on DAFNA Capital Management's 13F filing for Q1 2017, filed 15 May 2017.